Tumor P-Glycoprotein Correlates with Efficacy of PF-3758309 in in vitro and in vivo Models of Colorectal Cancer
P-glycoprotein (P-gp), a member of the ATP-binding cassette transporter family, is overexpressed in a number of different cancers and some studies show that P-gp overexpression can be correlated to poor prognosis or therapeutic resistance. Here we sought to elucidate if PF-3758309 (PF-309), a novel...
Main Authors: | Bradshaw-Pierce, Erica Lynn, Pitts, Todd M., Tan, Aik-Choon, McPhillips, Kelly, West, Mark, Gustafson, Daniel L., Halsey, Charles, Nguyen, Leslie, Lee, Nathan V., Kan, Julie L. C., Murray, Brion William, Eckhardt, S. Gail |
---|---|
Format: | Online |
Language: | English |
Published: |
Frontiers Media S.A.
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605511/ |
Similar Items
-
Association of the epithelial-to-mesenchymal transition phenotype with responsiveness to the p21-activated kinase inhibitor, PF-3758309, in colon cancer models
by: Pitts, Todd M., et al.
Published: (2013) -
Utilization of Quantitative In Vivo Pharmacology Approaches to Assess Combination Effects of Everolimus and Irinotecan in Mouse Xenograft Models of Colorectal Cancer
by: Bradshaw-Pierce, Erica L., et al.
Published: (2013) -
Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer
by: Pitts, Todd M., et al.
Published: (2014) -
Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model
by: Arcaroli, J J, et al.
Published: (2013) -
From Bench to Bedside: Lessons Learned in Translating Preclinical Studies in Cancer Drug Development
by: Lieu, Christopher H., et al.
Published: (2013)